Dermira Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
7,300.00
7,300.00
22,585.00
4,541.00
42,339
Cost of Goods Sold (COGS) incl. D&A
22.00
47.00
-
-
-
1,176
Gross Income
22.00
7,253.00
-
-
-
41,163
SG&A Expense
22,281.00
38,951.00
84,480.00
113,086.00
175,973.00
253,128
EBIT
22,303.00
31,698.00
77,252.00
90,624.00
171,771.00
211,965
Unusual Expense
-
78.00
2,518.00
-
128,555.00
2,017
Non Operating Income/Expense
38.00
71.00
896.00
1,540.00
5,205.00
7,887
Interest Expense
9.00
153.00
147.00
-
8,140.00
15,639
Pretax Income
22,350.00
31,844.00
79,021.00
89,084.00
303,261.00
221,734
Income Tax
-
31.00
622.00
-
-
194
Consolidated Net Income
22,350.00
31,875.00
78,399.00
89,084.00
303,261.00
221,540
Net Income
22,350.00
31,875.00
78,399.00
89,084.00
303,261.00
221,540
Net Income After Extraordinaries
22,350.00
31,875.00
78,399.00
89,084.00
303,261.00
221,540
Net Income Available to Common
22,350.00
31,875.00
78,399.00
89,084.00
303,261.00
221,540
EPS (Basic)
1.16
4.96
2.93
2.70
7.48
5.27
Basic Shares Outstanding
19,322.40
6,426.00
26,727.40
33,044.80
40,562.00
42,003
EPS (Diluted)
1.16
4.96
2.93
2.70
7.48
5.27
Diluted Shares Outstanding
19,322.40
6,426.00
26,727.40
33,044.80
40,562.00
42,003
EBITDA
22,281.00
31,651.00
77,180.00
90,501.00
171,432.00
211,410

About Dermira

View Profile
Address
275 Middlefield Road
Menlo Park California 94025
United States
Employees -
Website http://www.dermira.com
Updated 07/08/2019
Dermira, Inc. is a biopharmaceutical company, which engages in the provision of biotech ingenuity to medical dermatology. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis, and acne. The company was founded by Thomas G.